Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/30134
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | MULLENS, Wilfried | - |
dc.contributor.author | MARTENS, Pieter | - |
dc.date.accessioned | 2019-12-12T10:09:30Z | - |
dc.date.available | 2019-12-12T10:09:30Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | CIRCULATION, 139(11), p. 1366-1370 | - |
dc.identifier.uri | http://hdl.handle.net/1942/30134 | - |
dc.description.sponsorship | Dr Martens is supported by a doctoral fellowship by the Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek, Grant 1127917 N). Drs Martens and Mullens are researchers for the Limburg Clinical Research Program (LCRP) UHasselt-ZOL-Jessa, supported by the foundation Limburg Sterk Merk (LSM), Hasselt University, Ziekenhuis Oost-Limburg, and Jessa Hospital. | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.rights | 2019 American Heart Association, Inc. | - |
dc.subject.other | Editorials | - |
dc.subject.other | guideline | - |
dc.subject.other | heart failure | - |
dc.subject.other | heart ventricles | - |
dc.subject.other | mitral valve insufficiency | - |
dc.title | Sacubitril/ Valsartan to Reduce Secondary Mitral Regurgitation Refinement of Guideline- Directed Medical Therapy? | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 1370 | - |
dc.identifier.issue | 11 | - |
dc.identifier.spage | 1366 | - |
dc.identifier.volume | 139 | - |
local.format.pages | 5 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [Mullens, Wilfried; Martens, Pieter] Ziekenhuis Oost Limburg, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium. [Mullens, Wilfried] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, Diepenbeek, Belgium. [Martens, Pieter] Hasselt Univ, Doctoral Sch Med & Life Sci, Diepenbeek, Belgium. | - |
local.publisher.place | PHILADELPHIA | - |
local.type.refereed | Refereed | - |
local.type.specified | Editorial Material | - |
dc.identifier.doi | 10.1161/CIRCULATIONAHA.118.038135 | - |
dc.identifier.isi | 000469317100003 | - |
item.fullcitation | MULLENS, Wilfried & MARTENS, Pieter (2019) Sacubitril/ Valsartan to Reduce Secondary Mitral Regurgitation Refinement of Guideline- Directed Medical Therapy?. In: CIRCULATION, 139(11), p. 1366-1370. | - |
item.fulltext | With Fulltext | - |
item.accessRights | Open Access | - |
item.contributor | MULLENS, Wilfried | - |
item.contributor | MARTENS, Pieter | - |
crisitem.journal.issn | 0009-7322 | - |
crisitem.journal.eissn | 1524-4539 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
mullens 1.pdf | Published version | 1.1 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
28
checked on Aug 25, 2025
WEB OF SCIENCETM
Citations
28
checked on Sep 2, 2025
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.